Radiomics-Assisted Computed Tomography-Based Analysis to Evaluate Lung Morphology Characteristics after Congenital

Silviu-Viorel Virlan1, Matthias F Froelich1, Greta Thater1

  • 1Department of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.

PubMed

Insights

Radiomics analysis of pediatric chest CTs reveals significant lung morphology differences in patients after congenital diaphragmatic hernia (CDH) repair. This quantitative approach can aid in assessing lung hypoplasia and improving CDH patient outcomes.

Area of Science:

  • Pediatric Radiology
  • Medical Imaging Analysis
  • Thoracic Surgery

Background:

  • Congenital diaphragmatic hernia (CDH) leads to significant long-term lung morbidity in children.
  • Impaired lung function is a common complication following surgical repair of CDH.

Purpose of the Study:

  • To analyze lung morphology in pediatric patients post-CDH repair using radiomic-assisted feature extraction.
  • To identify quantitative radiomic features indicative of lung hypoplasia and treatment effects.

Main Methods:

  • Retrospective analysis of 72 pediatric patients who underwent CDH repair.
  • Acquisition of chest CT data using a third-generation dual-source CT scanner.
  • Application of dedicated software for image analysis, segmentation, and radiomics feature extraction.

Main Results:

  • Radiomics analysis successfully characterized lung morphology in CDH patients.
  • Statistically significant differences in shape and texture features were observed between ipsilateral and contralateral lungs.
  • Significant differences in shape features were found in contralateral lungs based on ECMO treatment, and a texture feature differed in ipsilateral lungs with/without ECMO.

Conclusions:

  • Radiomics-assisted feature analysis provides quantitative insights beyond visual assessment.
  • This method can serve as a future tool for evaluating lung hypoplasia severity in CDH patients.
  • Improved assessment may lead to enhanced therapeutic strategies and better outcomes for CDH patients.